Cabaletta Bio
CABA
97 hedge funds and large institutions have $623M invested in Cabaletta Bio in 2023 Q3 according to their latest regulatory filings, with 26 funds opening new positions, 47 increasing their positions, 10 reducing their positions, and 12 closing their positions.
370% more repeat investments, than reductions
Existing positions increased: 47 | Existing positions reduced: 10
117% more first-time investments, than exits
New positions opened: 26 | Existing positions closed: 12
100% more funds holding in top 10
Funds holding in top 10: 2 → 4 (+2)
94% more call options, than puts
Call options by funds: $1.44M | Put options by funds: $741K
32% more capital invested
Capital invested by funds: $470M → $623M (+$152M)
15% more funds holding
Funds holding: 84 → 97 (+13)
10.93% more ownership
Funds ownership: 91.81% → 102.75% (+11%)
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Holocene Advisors
New York
|
+$16.2M |
| 2 |
State Street
Boston,
Massachusetts
|
+$14.6M |
| 3 |
BlackRock
New York
|
+$10M |
| 4 |
CAM
Cormorant Asset Management
Boston,
Massachusetts
|
+$8.99M |
| 5 |
RG
Redmile Group
San Francisco,
California
|
+$5.52M |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
BC
Boxer Capital
San Diego,
California
|
-$6.97M |
| 2 |
Blackstone Inc
New York
|
-$6.44M |
| 3 |
PA
Perceptive Advisors
New York
|
-$5.64M |
| 4 |
Millennium Management
New York
|
-$4.79M |
| 5 |
FAM
Fred Alger Management
New York
|
-$4.28M |
CABA Hedge Fund Activity: Q3 2023 in Review
97 of the 6,301 institutional investors tracked by Wall St. Rank reported a position in Cabaletta Bio (CABA) for Q3 2023, worth a combined $623M — up 32% from $470M a quarter earlier.
Buyers outnumbered sellers: 26 funds opened new CABA positions and 12 closed out — a net gain of 14 holders — while 47 added to existing stakes and 10 trimmed.
The largest buyer was Holocene Advisors, opening a new position worth an estimated $16.2M. The largest seller was Boxer Capital, exiting entirely with an estimated $6.97M sold.
- 97 institutional investors held Cabaletta Bio (CABA) as of Q3 2023, up from 84 in Q2 2023.
- Funds reported $623M of Cabaletta Bio stock for Q3 2023, up 32% quarter-over-quarter.
- 26 funds opened new Cabaletta Bio positions in Q3 2023 and 12 closed out, a net change of +14 holders.
- The largest Cabaletta Bio buyer in Q3 2023 was Holocene Advisors, an estimated $16.2M added.
- The largest Cabaletta Bio seller in Q3 2023 was Boxer Capital, an estimated $6.97M sold.
Based on aggregated 13F filings for Q3 2023.